| Company/Division name | AbbVie |
| Parent company | AbbVie |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 300 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2029 |
| Domestically, the work will be done: | In-house |
| City reshored to: | North Chicago |
| State(s) reshored to: | IL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharma; API manufacturing |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies |
